{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T22:14:28Z","timestamp":1789942468413,"version":"4.0.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["semradonc.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Radiation Oncology"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.semradonc.2015.09.004","type":"journal-article","created":{"date-parts":[[2015,9,4]],"date-time":"2015-09-04T15:15:00Z","timestamp":1441379700000},"page":"3-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Breast Cancer Risk Assessment: Moving Beyond BRCA 1 and 2"],"prefix":"10.1016","volume":"26","author":[{"given":"Jennifer","family":"Scalia-Wilbur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley L.","family":"Colins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard T.","family":"Penson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don S.","family":"Dizon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semradonc.2015.09.004_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/caac.21254","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.semradonc.2015.09.004_bib2","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1126\/science.2270482","article-title":"Linkage of early-onset familial breast cancer to chromosome 17q21","volume":"250","author":"Hall","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.semradonc.2015.09.004_bib3","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1126\/science.8091231","article-title":"Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13","volume":"265","author":"Hall","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.semradonc.2015.09.004_bib4","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1186\/bcr1377","article-title":"Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource","volume":"8","author":"Mann","year":"2006","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.semradonc.2015.09.004_bib5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng.2007.53","article-title":"The emerging landscape of breast cancer susceptibility","volume":"40","author":"Stratton","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.semradonc.2015.09.004_bib6","unstructured":"NCCN clinical practice guidelines in oncology: genetic\/familial high-risk assessment: Breast and ovarian. Version 1; 2015. \u3008https:\/\/www.nccn.org\/store\/login\/login.aspx?ReturnURL=http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/genetics_screening.pdf\u3009"},{"key":"10.1016\/j.semradonc.2015.09.004_bib7","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1086\/374567","article-title":"Germline p53 mutations in a cohort with childhood sarcoma: Sex differences in cancer risk","volume":"72","author":"Hwang","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.semradonc.2015.09.004_bib8","first-page":"1298","article-title":"Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families","volume":"54","author":"Birch","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.semradonc.2015.09.004_bib9","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1136\/gut.2009.198499","article-title":"Peutz-Jeghers syndrome: A systematic review and recommendations for management","volume":"59","author":"Beggs","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.semradonc.2015.09.004_bib10","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1053\/gast.2000.20228","article-title":"Very high risk of cancer in familial Peutz-Jeghers syndrome","volume":"119","author":"Giardiello","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semradonc.2015.09.004_bib11","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1158\/1078-0432.CCR-11-2283","article-title":"Lifetime cancer risks in individuals with germline PTEN mutations","volume":"18","author":"Tan","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.semradonc.2015.09.004_bib12","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1200\/JCO.2007.12.5922","article-title":"CHEK2\u204e1100delC genotyping for clinical assessment of breast cancer risk: Meta-analyses of 26,000 patient cases and 27,000 controls","volume":"26","author":"Weischer","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2015.09.004_bib13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ng879","article-title":"Low-penetrance susceptibility to breast cancer due to CHEK2(\u204e)1100delC in noncarriers of BRCA1 or BRCA2 mutations","volume":"31","author":"Meijers-Hejiboer","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.semradonc.2015.09.004_bib14","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa1400382","article-title":"Breast-cancer risk in families with mutations in PALB2","volume":"371","author":"Antoniou","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semradonc.2015.09.004_bib15","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/ng1837","article-title":"ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles","volume":"38","author":"Renwick","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.semradonc.2015.09.004_bib16","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/ng1902","article-title":"Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles","volume":"38","author":"Seal","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.semradonc.2015.09.004_bib17","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1007\/s13277-013-0830-z","article-title":"Significant association between Nijmegen breakage syndrome 1 657del5 polymorphism and breast cancer risk","volume":"34","author":"Zhang","year":"2013","journal-title":"Tumour Biol"},{"key":"10.1016\/j.semradonc.2015.09.004_bib18","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1093\/emboj\/cdg429","article-title":"Full-length archaeal Rad51 structure and mutants: Mechanisms for RAD51 assembly and control by BRCA2","volume":"22","author":"Shin","year":"2003","journal-title":"EMBO J"},{"key":"10.1016\/j.semradonc.2015.09.004_bib19","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/ng.569","article-title":"Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene","volume":"42","author":"Meindl","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.semradonc.2015.09.004_bib20","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1200\/JCO.2013.53.6607","article-title":"Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment","volume":"32","author":"Kurian","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2015.09.004_bib21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/cncr.29010","article-title":"Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel","volume":"121","author":"Tung","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.semradonc.2015.09.004_bib22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1023\/A:1021135807900","article-title":"Risk models used to counsel women for breast and ovarian cancer: A guide for clinicians","volume":"1","author":"Claus","year":"2001","journal-title":"Fam Cancer"},{"key":"10.1016\/j.semradonc.2015.09.004_bib23","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/jnci\/93.5.358","article-title":"Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention","volume":"93","author":"Rockhill","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.semradonc.2015.09.004_bib24","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1158\/1055-9965.EPI-12-0570","article-title":"Which risk model to use? Clinical implications of the ACS MRI screening guidelines","volume":"22","author":"Ozanne","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.semradonc.2015.09.004_bib25","doi-asserted-by":"crossref","first-page":"441","DOI":"10.7326\/0003-4819-147-7-200710020-00002","article-title":"Validity of models for predicting BRCA1 and BRCA2 mutations","volume":"147","author":"Parmigiani","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semradonc.2015.09.004_bib26","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/bjc.2013.730","article-title":"BOADICEA breast cancer risk prediction model: Updates to cancer incidences, tumour pathology and web interface","volume":"110","author":"Lee","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.semradonc.2015.09.004_bib27","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/jmg.2007.056556","article-title":"Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: Validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics","volume":"45","author":"Antoniou","year":"2008","journal-title":"J Med Genet"},{"key":"10.1016\/j.semradonc.2015.09.004_bib28","unstructured":"BOADICEA\u2014Centre for Cancer Genetic Epidemiology. \u3008http:\/\/ccge.medschl.cam.ac.uk\/boadicea\/\u3009"},{"key":"10.1016\/j.semradonc.2015.09.004_bib29","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1471-2350-9-116","article-title":"Selecting a BRCA risk assessment model for use in a familial cancer clinic","volume":"9","author":"Panchal","year":"2008","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.semradonc.2015.09.004_bib30","unstructured":"BRCA-related cancer: Risk assessment, genetic counseling, and genetic testing. \u3008http:\/\/www.uspreventiveservicestaskforce.org\/Page\/Topic\/recommendation-summary\/brca-related-cancer-risk-assessment-genetic-counseling-and-genetic-testing?ds=1&s=BRCA\u3009"},{"key":"10.1016\/j.semradonc.2015.09.004_bib31","unstructured":"Familial Risk Assessment & Management. ASCO.org. \u3008http:\/\/www.asco.org\/practice-research\/familial-risk-assessment-management\u3009"},{"key":"10.1016\/j.semradonc.2015.09.004_bib32","doi-asserted-by":"crossref","first-page":"12629","DOI":"10.1073\/pnas.1007983107","article-title":"Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing","volume":"107","author":"Walsh","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semradonc.2015.09.004_bib33","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1056\/NEJMsr1501341","article-title":"Gene-panel sequencing and the prediction of breast-cancer risk","volume":"372","author":"Easton","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semradonc.2015.09.004_bib34","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/GIM.0b013e318207f564","article-title":"Genetic testing and cancer risk management recommendations by physicians for at-risk relatives","volume":"13","author":"Plon","year":"2011","journal-title":"Genet Med"},{"key":"10.1016\/j.semradonc.2015.09.004_bib35","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1200\/JCO.2012.46.9403","article-title":"Multiplex genetic testing for cancer susceptibility: Out on the high wire without a net?","volume":"31","author":"Domchek","year":"2013","journal-title":"J Clin Oncol"}],"container-title":["Seminars in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053429615000958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053429615000958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T18:26:50Z","timestamp":1537381610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053429615000958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S1053429615000958"],"URL":"https:\/\/doi.org\/10.1016\/j.semradonc.2015.09.004","relation":{},"ISSN":["1053-4296"],"issn-type":[{"value":"1053-4296","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Breast Cancer Risk Assessment: Moving Beyond BRCA 1 and 2","name":"articletitle","label":"Article Title"},{"value":"Seminars in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semradonc.2015.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}